The K@W Network:
Mylan, the now-infamous maker of the EpiPen allergy-treatment device, has raised outrage over out-sized price increases. Experts at Wharton and Penn Medicine explain the causes and the impact.
Some of your favorite foods -- sushi, extra virgin olive oil, Kobe beef, Parmesan cheese -- may not be what you think they are. Larry Olmsted explains in his new[…]
The recent case of a Maine restauranteur who said customers who owned a particular semiautomatic rifle would not be welcome at her restaurants raises questions about how much an owner’s[…]
New Wharton research examines the delicate balancing act among corporations, politicians and social activists.
Common wisdom says that despite being big shareholders, mutual funds have no real incentive to improve corporate governance. But new Wharton research shows that the opposite is true.
The debt disaster the U.S. territory is facing has its roots in a range of causes, some of which go back decades. But there are only a few options left[…]
The singer’s death and apparent lack of a will bring up thorny legal questions about who will manage his estate – including a likely treasure trove of unreleased music –[…]
Many think flawed bonus rules at financial institutions helped cause the financial crisis. But the evidence is thin, and new proposals to prevent a repeat may be easily thwarted.
The so-called “Panama Papers” track “dark money” flows globally over nearly four decades. They offer a rare opportunity for the U.K., the U.S. and other countries to check wrongdoings by[…]
Social entrepreneur Ron Cordes exhorted the audience at the Wharton Social Impact Conference to ask their financial advisors about impact investing, because “demand flows up.”